CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemia

[1] Eaves CJ(2010)Acute myeloid leukemia and the Wnt pathway N Engl J Med 362 2326-2327

[2] Humphries RK(2012)Current treatment of acute myeloid leukemia Curr Opin Oncol 24 711-719

[3] Roboz GJ(2017)Recent developments in immunotherapy of acute myeloid leukemia J Hematol Oncol 10 142-474

[4] Lichtenegger FS(2010)Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet Blood 115 453-10028

[5] Krupka C(1989)Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity Proc Natl Acad Sci U S A 86 10024-901

[6] Haubner S(1991)The cytoplasmic domain of the T cell receptor zeta chain is sufficient to couple to receptor-associated signal transduction pathways Cell 64 891-60

[7] Kohnke T(2013)Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology Immunity 39 49-1044

[8] Subklewe M(2017)Chimeric antigen receptor T cells: a novel therapy for solid tumors J Hematol Oncol 10 78-433

[9] Dohner H(2010)Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor Blood 116 1035-4828

[10] Estey EH(2014)The human application of gene therapy to re-program T-cell specificity using chimeric antigen receptors Chin J Cancer. 33 421-2720

[1] Eaves CJ(2010)Acute myeloid leukemia and the Wnt pathway N Engl J Med 362 2326-2327

[2] Humphries RK(2012)Current treatment of acute myeloid leukemia Curr Opin Oncol 24 711-719

[3] Roboz GJ(2017)Recent developments in immunotherapy of acute myeloid leukemia J Hematol Oncol 10 142-474

[4] Lichtenegger FS(2010)Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet Blood 115 453-10028

[5] Krupka C(1989)Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity Proc Natl Acad Sci U S A 86 10024-901

[6] Haubner S(1991)The cytoplasmic domain of the T cell receptor zeta chain is sufficient to couple to receptor-associated signal transduction pathways Cell 64 891-60

[7] Kohnke T(2013)Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology Immunity 39 49-1044

[8] Subklewe M(2017)Chimeric antigen receptor T cells: a novel therapy for solid tumors J Hematol Oncol 10 78-433

[9] Dohner H(2010)Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor Blood 116 1035-4828

[10] Estey EH(2014)The human application of gene therapy to re-program T-cell specificity using chimeric antigen receptors Chin J Cancer. 33 421-2720